Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Comprehensive Digestive Institute of Nevada (CDIN) is a specialized gastroenterology practice and clinical research center based in Southern Nevada. The institute provides comprehensive diagnostic and therapeutic services for a wide range of digestive and liver diseases, including inflammatory bowel disease, hepatitis, and gastrointestinal cancers. CDIN operates a dedicated clinical research division that partners with global pharmaceutical companies to conduct Phase 2 and Phase 3 clinical trials for novel GI therapies. In 2021, the practice joined GI Alliance, the nation's largest network of gastroenterology specialists, to enhance its clinical resources and patient reach. The institute is led by board-certified gastroenterologists and maintains multiple state-of-the-art facilities in Las Vegas and Henderson. Its dual focus on high-quality patient care and clinical innovation makes it a key player in the regional healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Comprehensive Digestive Institute of Nevada.